| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci (coagulase-negative) |
0.03 |
8 |
≤0.015 － >=64 |
Cethromycin (ABT-773)  |
950 |
| Staphylococci (coagulase-negative) |
0.047 |
0.19 |
? － ? |
Imipenem |
323 |
| Staphylococci (coagulase-negative) |
0.05 |
0.78 |
0.025 － 1.56 |
Garenoxacin (T-3811, BMS-284756) |
17 |
| Staphylococci (coagulase-negative) |
0.05 |
1.56 |
0.025 － 1.56 |
Trovafloxacin (Trovan) |
17 |
| Staphylococci (coagulase-negative) |
0.06 |
2 |
≤0.03 － >4 |
Trovafloxacin (Trovan) |
462 |
| Staphylococci (coagulase-negative) |
>0.06 |
>16 |
0.03 － >16 |
Solithromycin (CEM-101 and OP-1068) |
1130 |
| Staphylococci (coagulase-negative) |
0.06 |
32 |
0.03 － >=64 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
950 |
| Staphylococci (coagulase-negative) |
0.12 |
0.25 |
0.03 － 1 |
Tigecycline (GAR-936, Tigacyl) |
6 |
| Staphylococci (coagulase-negative) |
0.12 |
0.5 |
≤0.06 － 0.5 |
Minocycline (Minocycline hydrochloride, Minocin) |
462 |
| Staphylococci (coagulase-negative) |
0.12 |
4 |
0.015 － 32 |
Imipenem |
1491 |
| Staphylococci (coagulase-negative) |
>0.12 |
>4 |
≤0.12 － >4 |
Clindamycin (Cleocin) |
1130 |
| Staphylococci (coagulase-negative) |
>0.12 |
>8 |
≤0.06 － >8 |
Clindamycin (Cleocin) |
472 |
| Staphylococci (coagulase-negative) |
>0.12 |
>16 |
0.03 － >16 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
1130 |
| Staphylococci (coagulase-negative) |
0.25 |
0.5 |
0.03 － 1 |
Tigecycline (GAR-936, Tigacyl) |
472 |
| Staphylococci (coagulase-negative) |
0.25 |
0.5 |
≤0.06 － 1 |
Tigecycline (GAR-936, Tigacyl) |
462 |
| Staphylococci (coagulase-negative) |
0.25 |
0.5 |
0.06 － 2 |
Daptomycin (Cubicin) |
472 |
| Staphylococci (coagulase-negative) |
0.25 |
0.5 |
≤0.25 － >8 |
Quinupristin/Dalfopristin (Synercid) |
472 |
| Staphylococci (coagulase-negative) |
0.25 |
1 |
0.12 － 4 |
Quinupristin/Dalfopristin (Synercid) |
6 |
| Staphylococci (coagulase-negative) |
>0.25 |
>2 |
≤0.25 － >2 |
Clindamycin (Cleocin) |
462 |
| Staphylococci (coagulase-negative) |
>0.25 |
>4 |
0.12 － >4 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
462 |
| Staphylococci (coagulase-negative) |
>0.25 |
>4 |
≤0.25 － >4 |
Trimethoprim/Sulfamethoxazole |
1130 |
| Staphylococci (coagulase-negative) |
>=0.25 |
≥64 |
0.03 － >=64 |
Clarithromycin (Biaxin) |
950 |
| Staphylococci (coagulase-negative) |
0.38 |
1.5 |
? － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
323 |
| Staphylococci (coagulase-negative) |
0.39 |
3.13 |
0.1 － 3.13 |
Levofloxacin (Levaquin, Quixin) |
17 |
| Staphylococci (coagulase-negative) |
0.39 |
6.25 |
0.05 － 6.25 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
17 |
| Staphylococci (coagulase-negative) |
0.5 |
0.5 |
0.25 － 2 |
Quinupristin/Dalfopristin (Synercid) |
1130 |
| Staphylococci (coagulase-negative) |
0.5 |
1 |
0.25 － 1 |
RWJ-416457 |
189 |
| Staphylococci (coagulase-negative) |
0.5 |
1 |
0.5 － 1 |
Daptomycin (Cubicin) |
483 |